A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer
Clinical trial NCT00191490 · COMPLETED
Trial details
- NCT number
- NCT00191490
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.